SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-19-027585
Filing Date
2019-05-07
Accepted
2019-05-07 19:40:58
Documents
1
Period of Report
2019-01-01

Document Format Files

Seq Description Document Type Size
1 3/A a3a.html 3/A  
1 3/A a3a.xml 3/A 11823
  Complete submission text file 0001104659-19-027585.txt   13317
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
Nally Michael (Reporting) CIK: 0001763945 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-06571 | Film No.: 19804776